| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Wnt/beta-catenin signaling pathway as a novel cancer drug target. | Curr Cancer Drug Targets | 2004 | 1.72 |
| 2 | Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. | Lung Cancer | 2007 | 1.01 |
| 3 | Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics. | Curr Pharm Des | 2005 | 0.90 |
| 4 | Novel MDM2 p53-independent functions identified through RNA silencing technologies. | Ann N Y Acad Sci | 2005 | 0.80 |